Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T15:36:36.244Z.
Calculation as of: 2026-10-06T15:36:36.244Z.
Quote observation: 2026-10-06T15:34:28.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f130e36c5816a2cced4d00ccb7d778b7baaa6bfdcaf5b95b3974dc9f748ee68d
PEG RATIO
N/A
FibroBiologics, Inc. Common Stock
Market Cap
$2.58M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| FibroBiologics, Inc. Common Stock (FBLG) | $2.58M | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.55M | N/A |
| Nuwellis, Inc. (NUWE)vs › | $2.62M | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.52M | N/A |
| iSpecimen Inc. (ISPC)vs › | $2.64M | N/A |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.48M | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.33M | N/A |
| Onconetix, Inc. (ONCO)vs › | $2.33M | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.33M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.04M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
